 |
 |
|
|
|
|
 |
The two problems that men face with increasing age are prostate problems and decrease in testosterone levels. Surprisingly both are different sides of the same coin. Prostate problems appear to arise from increased metabolism of testosterone into dihydrotestosterone (DHT), whereas increased body fat drives testosterone into estrogen, decreasing testosterone levels. Zone Prostate Health is a unique, premium product that combines saw palmetto with zinc to help regulate DHT production and aid in healthy male reproduction.1,2 DHT lowers testosterone levels and increases the likelihood of prostate problems. Saw palmetto is a small palm tree found in the southern United States, and the berries from the palm have been used medicinally for hundreds of years. The extract from saw palmetto berries is believed to promote prostate health, as well as regulate urine flow resulting in frequent urination, and promote a healthy urinary tract.3,4,5 Researchers have demonstrated that saw palmetto helps maintain testosterone levels by regulating its conversion into DHT thus maintaining prostate health.6,7,8 Zinc is a very important mineral in maintaining men’s health. Zinc is necessary for all aspects of male reproduction, including healthy testosterone modulation.9*
- Helps to maintain a healthy prostate
- Promotes a healthy urinary tract10,11
- Helps to maintain testosterone levels by regulating the production of dihydrotestosterone (DHT)
- Plays a role in the maintenance of a healthy male reproductive system
- Helps maintain prostate health by adjusting testosterone levels
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Supplement Facts
Prostate Health and the Zone Wellness Pyramid
References
Supplement Facts
Serving Size: One Capsule
Servings Per Container: 60 |
|
 |
|
|
Amount
Per Serving |
% Daily
Value* |
|
|
Zinc (Gluconate 13%) |
5 |
mg |
33% |
|
|
Saw Palmetto Extract 4:1 |
250 |
mg |
** |
|
|
*Percent Daily Values are based on a 2,000 calorie diet.
** Daily Value Not Established |
|
| Other Ingredients: Gelatin, Maltodextrin, Magnesium Stearate, Silicon Dioxide. | |
Dr. Sears’ recommendations for Prostate Health are based on principles of the Zone Wellness Pyramid. These principles are imperative to follow in order to maintain normal levels of testosterone while regulating its metabolism into DHT that can lead to prostate problems.
To help reduce excess body fat you have to stabilize insulin levels with the Zone Diet by consuming a balance low-glycemic load carbohydrates and low-fat protein. The healthy reduction in excess body fat helps reduce the levels of aromatase, the enzyme that converts testosterone into estrogen.
4 capsules per day. Ultra-Refined EPA/DHA concentrates have the ability to maintain normal testosterone production by regulating the development of bad or pro-inflammatory eicosanoids. EPA acts as a regulator of the delta-5 desaturase enzyme thereby regulating the overproduction of Arachidonic Acid (AA). Helping reduce silent inflammation promotes the efficiency of the release of certain hormones that are required for normal testosterone production. Initially start with 4 capsules of OmegaRx for 30 days to regulate the production of pro-inflammatory eicosanoids. Once the levels of EPA and DHA stabilize, gradually start replacing some of the OmegaRx with EicoRx to promote the up-regulation of anti-inflammatory eicosanoids.
2 tablespoons (30 ml) per day. The polyphenols in SeaHealth Plus have antioxidant properties that help regulate free radicals. These polyphenols also activate the enzyme AMP kinase that directs incoming nutrients to ATP production as opposed to fat storage, helping to reduce body fat.
Take 2 capsules daily. Once you have established the Zone Wellness Pyramid as your dietary program, then consider adding Prostate Health as a function-specific supplement. Saw palmetto extract has been shown to help regulate the metabolism of testosterone into DHT. Zinc is required to help maintain normal testosterone production.12
1 Bayne, C, et al, “The Selectivity and Specificity of the Actions o fthe Lipido-Sterolic Extract of Serenoa Repens (Permixon) on the Prostate.” The Journal of Urology, 2000; 164(3):876-881.
2 Ae-Son, OM, et al, “Dietary Zinc Deficiency Alters 5-Alpha-Reduction and Aromatization of Testosterone and Androgen and Estrogen Receptors in Rat Liver.” Journal of Nutrition, 1996; 126(4):842-848.
3 Talpur N, et al, “Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.” Molecular and Cellular Biology, 2003; 250:21-26.
4 Pytel Y.A. et al, “Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia.” Advances in Therapy, 2002; 19(6):297-306.
5 Talpur N, et al, “Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats.” Molecular and Cellular Biology, 2003; 250:21-26.
6 Bayne, C, et al, “The Selectivity and Specificity of the Actions o fthe Lipido-Sterolic Extract of Serenoa Repens (Permixon) on the Prostate.” The Journal of Urology, 2000; 164(3):876-881.
7 Ernst, E, et al, “The Risk-Benefit Profile of Commonly Used Herbal Therepies.” Annals of Internal Medicine, 2002; 136(1):42-53.
8 Buck A.C. et al, “Is there a scientific basis for the therapeutic effects of Serenoa repens in benigh prostatic hyperplasia?” The Journal of Urolgoy, 2004; 172(5): 1792-1799.
9 Prasad, AS, et al, “Zinc status and serum testosterone levels of healthy adults.” Nutrition, 1996; 12:344-348.
10 Gerber S. et al, “Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.” Urology, 2001; 58: 960-965.
11 Wilt T, MD, et al, “Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia.” The Journal of the American Medical Association, 1998; 280:1604-1609.
12 Mahajan, SK, et al, “Effect of oral zinc therapy on gonadal function in hemodialysis patients. A double-blind study.” Annals of Internal Medicine, 1982; 97(3):357-361. |
|
|
|
|
|
|
|